When compared to healthy controls, patients with bladder cancer have greater levels of urine- and plasma-soluble proteins such as VEGF, endostatin, stress proteins, and cytokines, which aid in the detection and staging of the disease [10]. This evidence concerns the gene VEGFA and urinary bladder cancer.